Caitlin Clark may be an all-star on the basketball court, but she couldn’t beat Eli Manning when it came to a game of Pop-A-Shot. On the latest episode of The Eli Manning Show, the former NFL ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now ...

Eli Manning’s still got it — even off the football field. The legendary Giants quarterback, 44, faced off against WNBA star Caitlin Clark in a recent round of Pop-A-Shot on “The Eli Manning ...

Eli Manning may not be done as a Giant just yet. The two-time Super Bowl MVP, who missed out on his first try for the Pro Football Hall of Fame earlier this month, said Friday he would have ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45% for the last ...

Rockstar Games may bring back a controversial feature from Red Dead Redemption 2, and some of its other previous games, including some older GTA games, with the release of GTA 6. Grand Theft Auto ...

Former Giants quarterback Eli Manning has previously expressed interest in NFL ownership, specifically with his former team. “It’s definitely something of interest,” Manning said in an ...

US President Donald Trump watched translated excerpts of an interview given by captivity survivor Eli Sharabi to the "Uvda" program, and invited him and other captivity survivors to the White ...

Rep. Eli Crane, R-Ariz., said this week he was drafting articles of impeachment against U.S. District Judge Paul Engelmayer of the U.S Southern District of New York, who on Saturday blocked the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. A bunch of people I know (including me) have gotten sick ...